Rituximab for TTP [2]

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 87-88

  Scott, Sarah M ^a   Szczepiorkowski, Zbigniew M ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; METALLOPROTEINASE; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

CASE REPORT; CHILL; CONFUSION; FEMALE; FEVER; HEADACHE; HUMAN; INFERTILITY; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; GENE DELETION; GENETICS; NOTE;

ADAM PROTEINS; ANTIBODIES, MONOCLONAL; GENE DELETION; HUMANS; METALLOENDOPEPTIDASES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VON WILLEBRAND FACTOR;

EID: 24344503236     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20364     Document Type: Letter

References (5)

1. Ahmad A, Aggarwal A, Sharma A, et al. Rituximab for treatment of refractory/ relapsing thrombotic thrombocytopenic purpura. Am J Hematol 2004;77:171-176.
2. Gutterman L, Kloster B, Tsai H-M. Rituximab therapy for refractory thrombotic thrombocytopenic purpura. Blood Cells Mol Dis 2002;28:385-391.
3. Yomtovian R, Niklinski W, Silver B, et al. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br J Haematol 2004;124:787-795.
4. Vesely S, Li X, McMinn JR, et al. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004; 44(8):1149.
5. Ducloy-Bouthors AS, Caron C, Subtil D, et al. Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;111(2):146-152.